Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Pricing of Public Offering of Common Stock
February 15, 2018 05:00 ET | Avid Bioservices, Inc
TUSTIN, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) today announced the pricing of an underwritten public offering of 9,000,000 shares of its common...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Proposed Offering of Common Stock
February 14, 2018 16:02 ET | Avid Bioservices, Inc
TUSTIN, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) today announced that it has commenced an underwritten public offering of its common stock.  Avid...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
February 12, 2018 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif. and BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Oncologie, Inc. today announced that the companies have entered into an...